<DOC>
	<DOCNO>NCT01660763</DOCNO>
	<brief_summary>The purpose study compare efficacy safety Sufentanil NanoTab PCA System/15 mcg Placebo Sufentanil NanoTab PCA System management acute moderate severe post-operative pain total unilateral knee total unilateral hip replacement surgery .</brief_summary>
	<brief_title>Efficacy Safety Trial Evaluate Sufentanil NanoTab® PCA System/15 mcg ( Zalviso™ ) Post-Operative Pain Patients After Knee Hip Replacement Surgery</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<criteria>Male female patient 18 year age old Patients schedule elective cement uncemented total unilateral knee replacement total unilateral hip replacement , general spinal anesthesia include use intrathecal opioid Postsurgical patient admit PACU expect remain hospitalized acute postoperative pain require parenteral opioids least 48 hour surgery Patients undergone replacement knee hip Patients take opioid 30 consecutive day , daily dose 15 mg morphine ( equivalent ) , within past 3 month prior surgery ( e.g . 3 dos per day Vicodin® , Norco® , Lortab® 5 mg hydrocodone per tablet ) Patients allergy hypersensitivity opioids</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>